Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2005
11/03/2005US20050245553 Amino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl chloromethanesulfonate; cardiovascular disorders, thromboembolic disorders, inflammation, and disorders of the central nervous system
11/03/2005US20050245552 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis
11/03/2005US20050245551 Amide derivatives
11/03/2005US20050245545 administering a xanthine derivative such as (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine
11/03/2005US20050245537 Use of compounds having ccr antagonism
11/03/2005US20050245527 Nitrogen containing heterocyclic compounds and medicines containing the same
11/03/2005US20050245522 Novel compounds
11/03/2005US20050245520 2-Phenylpyridin-4-yl derivatives as alk5 inhibitors
11/03/2005US20050245513 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
11/03/2005US20050245512 Method and composition for rejuvinating cells, tissues organs, hair and nails
11/03/2005US20050245511 Novel compounds that inhibit tryptase activity
11/03/2005US20050245507 7-Phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents
11/03/2005US20050245504 Treatment of diseases with combinations of alpha 7 Nicotinic Acetylcholine Receptor agonists and other compounds
11/03/2005US20050245503 Therapeutic heterocycles
11/03/2005US20050245486 Prostate specific membrane antigen (PSMA); for diagnosis, detection and treatment of cancer; gene overexpression; kits
11/03/2005US20050245483 Matrix for sustained, invariant and independent release of active compounds
11/03/2005US20050245436 Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis
11/03/2005US20050244965 culturing with an effective amount of granulocyte-macrophage colony stimulating factor, using brain tissue cells; transplantation; treating multiple sclerosis demyelination
11/03/2005US20050244896 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
11/03/2005US20050244877 Splice variants of CD40-receptor
11/03/2005US20050244812 Kits and methods for detection of apoptotic cells
11/03/2005US20050244508 Anti-spasmodic comprising xenon
11/03/2005US20050244406 Monoclonal antibodies against extracellular loops of c5ar
11/03/2005US20050244392 Probiotic strains, a process for the selection of them, compositions thereof, and their use
11/03/2005US20050244382 Compositions including ammonia oxidizing bacteria and methods of using same
11/03/2005US20050244381 Adenovirus including a gene coding for a superoxide dismutase
11/03/2005CA2605574A1 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
11/03/2005CA2565219A1 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
11/03/2005CA2563826A1 Treatment of cns disorders using cns target modulators
11/03/2005CA2563741A1 Antisense oligonucleotides against cpla2, compositions and uses thereof
11/03/2005CA2563707A1 Method of treating neuropathic pain using a crth2 receptor antagonsit
11/03/2005CA2563687A1 Use of a cgrp-antagonist combined with a serotonin-reuptake inhibitor in order to treat migraines
11/03/2005CA2563635A1 Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine a2a receptor antagonists
11/03/2005CA2563491A1 Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol, and applications thereof
11/03/2005CA2563356A1 Combinations comprising alpha-2-delta ligands and ep4 receptor antagonists
11/03/2005CA2559038A1 Processes for preparing substituted n-aryl-n'-[3-(1h-pyrazol-5-yl) phenyl] ureas and intermediates thereof
11/02/2005EP1591453A1 Modified peptides yy and conjugates thereof
11/02/2005EP1591446A1 Thienopyrimidine compounds and use thereof
11/02/2005EP1591444A1 CCR5 antagonists useful for treating aids
11/02/2005EP1591129A2 Use of neurotoxic component of botulinum toxin for treating pain associated with cervical dystonia or bepharospasm
11/02/2005EP1591119A2 Pramipexole for treating CNS diseases, especially Parkinson's disease
11/02/2005EP1590369A2 Human il-1 beta antagonists
11/02/2005EP1590346A1 4- {'3-(sulfonylamino) phenyl! '1-(cyclymethyl) piperidin-4-ylidene! methyl} benazmide derivatives as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder
11/02/2005EP1590337A1 Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors
11/02/2005EP1590333A1 Glycogen synthase kinase 3beta inhibitor, composition and process for the preparation thereof
11/02/2005EP1590326A2 Substituted alkyl amido piperidines
11/02/2005EP1590321A2 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/02/2005EP1589979A2 Compounds for the normalization of the sleep/wake cycle
11/02/2005EP1589974A2 Use of n-desmethylclozapine to treat human neuropsychiatric disease
11/02/2005EP1589964A1 Compounds having anti-proliferative properties
11/02/2005EP1507758B1 Indole derivatives and their use as ligands for cb2 receptors
11/02/2005EP1501833B1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1501525B1 Method for producing preparations rich in tocotrienol
11/02/2005EP1501515B1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1472256B1 Piperidine derivatives
11/02/2005EP1446402B1 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase
11/02/2005EP1377569B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
11/02/2005EP1373254B1 Process for the preparation of the anti-migraine drug eletriptan
11/02/2005EP1332149B1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
11/02/2005EP1296691B1 Use of cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infections
11/02/2005EP1292304B1 Zolpidem hemitartrate
11/02/2005EP1278719B1 Naphthamide neurokinin antagonists for use as medicaments
11/02/2005EP1246807B1 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
11/02/2005EP1237902B1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase
11/02/2005EP1169244B1 Metering valve
11/02/2005EP1168923B1 Dna vaccination for treatment of autoimmune disease
11/02/2005EP1157000B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
11/02/2005EP1080095B1 Modulators of protein tyrosine phosphatases (ptpases)
11/02/2005EP1059916B1 Extended release dosage form
11/02/2005EP1045833B1 2,3-substituted indole compounds as cox-2 inhibitors
11/02/2005EP0951537B1 Recombinant collagen produced by plants, methods for obtaining them and uses
11/02/2005CN1692116A Adenosine A2A receptor antagonists
11/02/2005CN1692115A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
11/02/2005CN1692102A Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases
11/02/2005CN1692100A 4[piperidin-4-yliden-(3-carbamoylphenyl)methyl]benzamide derivatives and their use for the treatment of pain spinal injuries or gastrointestinal disorders
11/02/2005CN1691960A Inhibitors for continuous activation of calcineurin
11/02/2005CN1691957A 蛋白酶抑制剂 Protease inhibitors
11/02/2005CN1691947A Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
11/02/2005CN1691945A Use of rapamycin for inhibiting of cell death
11/02/2005CN1691944A Oxadiazoles as modulators of metabotropic glutamate receptor-5
11/02/2005CN1690203A Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
11/02/2005CN1689563A Application of butylbenzene phthalein homolog in preparation of medicine for treating cerebral ischemia disease
11/02/2005CN1225465C Novel compounds
11/02/2005CN1225462C New piperazine and piperidine compounds
11/02/2005CN1225277C Chinese medicinal composition for treating epilepsy disease and its preparation method
11/02/2005CN1225274C Medicine for treating neurasthenia and producing method
11/02/2005CN1225269C Medicine for treating prospoalgia
11/02/2005CN1225250C Efficacious parts compositions of Chinese medicine for prevention and treatment of senile dementia and preparation method
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
11/01/2005US6960683 Antiinflammatory agents; autoimmune diseases; cardiovascular disorders
11/01/2005US6960664 Aza hydroxylated ethyl amine compounds
11/01/2005US6960648 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents
11/01/2005US6960614 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids
11/01/2005US6960613 administering (S)-1-[3-(dimethyl-amino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile or a salt; selective, centrally acting serotonin reuptake inhibitor for panic attacks and obsessive compulsive disorders
11/01/2005US6960612 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/01/2005US6960609 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents
11/01/2005US6960605 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
11/01/2005US6960602 Piperidine derivatives as modulators of chemokine receptors
11/01/2005US6960601 Imidazole derivatives; appetite suppressants
11/01/2005US6960599 Dopamine D2 receptor and 5-HT1A antagonists; schizophrenia; cognitive activators; Alzheimer's disease; brain disorders; strokes; antiischemic agents; anxiolytic agents; obsessive compulsive disorder; eating, sleeping and sexual disorders
1 ... 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 ... 1833